We are live on ! Find out more
MBOT icon

Microbot Medical

33 hedge funds and large institutions have $1.77M invested in Microbot Medical in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

3.2% less ownership

Funds ownership: 13.26%10.06% (-3.2%)

8% less funds holding

Funds holding: 3633 (-3)

31% less capital invested

Capital invested by funds: $2.57M → $1.77M (-$798K)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
33
Holders Change
-3
Holders Change %
-8.33%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
5
Closed
8
Calls
$11K
Puts
Net Calls
+$11K
Net Calls Change
-$31K

MBOT Hedge Fund Activity: Q1 2024 in Review

33 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2024, worth a combined $1.77M — down 31% from $2.57M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MBOT and 5 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 8 added.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $510K. The largest seller was Armistice Capital, exiting entirely with an estimated $492K sold.

  • 33 institutional investors held Microbot Medical (MBOT) as of Q1 2024, down from 36 in Q4 2023.
  • Funds reported $1.77M of Microbot Medical stock for Q1 2024, down 31% quarter-over-quarter.
  • 5 funds opened new Microbot Medical positions in Q1 2024 and 8 closed out, a net change of -3 holders.
  • The largest Microbot Medical buyer in Q1 2024 was Hudson Bay Capital Management, an estimated $510K added.
  • The largest Microbot Medical seller in Q1 2024 was Armistice Capital, an estimated $492K sold.

Based on aggregated 13F filings for Q1 2024.